Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGRX | F | Agile Therapeutics, Inc. | -8.37 | |
NKTR | B | Nektar Therapeutics | -7.58 | |
ATRA | F | Atara Biotherapeutics, Inc. | -7.35 | |
MCRB | D | Seres Therapeutics, Inc. | -5.88 | |
AFMD | D | Affimed Therapeutics B.V. | -4.74 | |
NVAX | D | Novavax, Inc. | -4.73 | |
BLRX | F | BioLineRx Ltd. | -4.64 | |
LXRX | D | Lexicon Pharmaceuticals, Inc. | -4.10 | |
ONCT | C | Oncternal Therapeutics, Inc. | -3.65 | |
SAGE | F | Sage Therapeutics, Inc. | -2.94 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biotechnology
Biopharmaceutical
Cancer
Immune System
Blastoma
Cancer Treatment
Glioblastoma
Immunology
Monoclonal Antibody
Acute Myeloid Leukemia
Autoimmune Disease
Brain Tumor
Cancer Cell
Chemotherapy
Clinical Medicine
Drugs
Glioblastoma Multiforme
Immunotherapy
Oncology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | D | iShares Neuroscience and Healthcare ETF | 10.03 | |
PINK | D | Simplify Health Care ETF | 8.61 | |
BBP | C | BioShares Biotechnology Products Fund | 8.18 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 7.13 | |
BBH | C | Market Vectors Biotech ETF | 5.33 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles